OptiScan Biomedical

OptiScan Biomedical is a medical device company dedicated to developing glucose monitoring systems for Intensive Care Units (ICU) / Coronary Care Units (CCU). Its product, the OptiScanner 5000, is the first automated bedside blood glucose monitoring system that directly measures blood glucose levels using spectroscopy without the need for calibration. OptiScanner Biomedical Corporation has developed an innovative monitoring platform for use in hospital intensive care units (ICU) to support clinicians in detecting changes in critically ill patients more quickly, enabling more timely interventions. The OptiScanner® platform currently focuses on providing automated bedside glucose monitoring, informing clinical decision-making, and maintaining user-defined target glucose ranges.